首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis.
【24h】

Interference in the Limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis.

机译:用于腹膜透析液和血液透析浓缩液中endo毒素测定的am变形细胞溶胞产物测定的干扰。

获取原文
获取原文并翻译 | 示例
       

摘要

The interference of the saline concentration of fluids for peritoneal dialysis and concentrates for hemodialysis on the Limulus amebocyte lysate (LAL) assay for endotoxins was investigated. The experiments were carried out individually with each substance that compose fluids for hemodialysis, to determine the possible inhibition or enhancement effects that they could cause on the LAL assay. The compositions were also assayed to investigate the possibility of synergistic effect. They were assayed by the gel-clot method from two different suppliers, and the samples that showed inhibition effect were also assayed by the chromogenic method. The samples were analysed at successive dilutions, with different LAL sensitivities, to satisfy the endotoxin limits of 5 EU/ml for the concentrate and 0.25 EU/ml for the fluid for dialysis peritoneal. The results showed that the major interference on the gel-clot assay occurs in presence of acetic acid and in concentrates containing acid acetic, even the pH being adjusted between 6.5 and 7.5. However, the test, after an adequate dilution, could be validating for all samples. Chromogenic test can be used for peritoneal dialysis fluids considering a limit of 0.25 EU/ml and sample dilution of eight times, but it cannot be used for concentrates for hemodialysis without further dilution. Considering the results and that the chromogenic is a more time-consuming method, endotoxins in fluids for hemodialysis can be satisfactorily assayed by the gel-clot method.
机译:腹水透析液和血液透析浓缩液的盐水浓度对am内毒素的am变形细胞裂解液(LAL)检测的影响进行了研究。对构成血液透析液的每种物质分别进行了实验,以确定它们可能对LAL分析产生的抑制或增强作用。还测定了组合物以研究协同作用的可能性。通过凝胶电泳法从两个不同的供应商处对它们进行了测定,并且还通过生色法对显示出抑制作用的样品进行了测定。以不同的LAL敏感性在连续稀释下对样品进行分析,以满足内毒素限值:浓缩液浓度为5 EU / ml,腹膜透析液的浓度为0.25 EU / ml。结果表明,凝胶凝集测定的主要干扰发生在存在乙酸和含有酸性乙酸的浓缩物中,甚至将pH值调节在6.5至7.5之间。但是,在充分稀释后,该测试可以对所有样品进行验证。考虑到极限浓度为0.25 EU / ml和样品稀释度为8倍,可以对腹膜透析液进行显色测试,但如果不进一步稀释,则不能用于血液透析浓缩液。考虑到结果以及显色是一种更耗时的方法,可以通过凝胶凝结法令人满意地测定血液透析液中的内毒素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号